{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:51:42Z","timestamp":1779277902979,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bbrc.2016.05.058","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T15:50:16Z","timestamp":1463068216000},"page":"69-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Restoration of the cellular secretory milieu overrides androgen dependence of in\u00a0vivo generated castration resistant prostate cancer cells overexpressing the androgen receptor"],"prefix":"10.1016","volume":"476","author":[{"given":"Mugdha","family":"Patki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manohar","family":"Ratnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.05.058_bib1","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1158\/0008-5472.CAN-11-0532","article-title":"Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors","volume":"71","author":"Cai","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.05.058_bib2","first-page":"1809","article-title":"LNCaP model of human prostatic carcinoma","volume":"43","author":"Horoszewicz","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.05.058_bib3","first-page":"2892","article-title":"Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen","volume":"61","author":"Gregory","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.05.058_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm972","article-title":"Molecular determinants of resistance to antiandrogen therapy","volume":"10","author":"Chen","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.05.058_bib5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/pros.22473","article-title":"Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure","volume":"72","author":"Urbanucci","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.bbrc.2016.05.058_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/me.2010-0469","article-title":"Minireview: alternative activation pathways for the androgen receptor in prostate cancer","volume":"25","author":"Lamont","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbrc.2016.05.058_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrurol.2015.13","article-title":"Are androgen receptor variants a substitute for the full-length receptor?","volume":"12","author":"Lu","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbrc.2016.05.058_bib8","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2016.05.058_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1470-2045(14)71205-7","article-title":"Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study","volume":"16","author":"Ryan","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2016.05.058_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.2014.56.5119","volume":"33","author":"Fizazi","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2016.05.058_bib11","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-11-3948","article-title":"ARN-509: a novel antiandrogen for prostate cancer treatment","volume":"72","author":"Clegg","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.05.058_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4070","article-title":"ROR-gamma drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.05.058_bib13","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/pros.22674","article-title":"Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer","volume":"73","author":"Guerrero","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.bbrc.2016.05.058_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2016.05.058_bib15","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1073\/pnas.1012443107","article-title":"Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor","volume":"107","author":"Watson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2016.05.058_bib16","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1074\/jbc.M112.438473","article-title":"The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells","volume":"288","author":"Patki","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2016.05.058_bib17","first-page":"163","article-title":"VCaP, a cell-based model system of human prostate cancer","volume":"15","author":"Korenchuk","year":"2001","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.bbrc.2016.05.058_bib18","first-page":"2577","article-title":"Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer","volume":"54","author":"Thalmann","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2016.05.058_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11626-999-0115-4","article-title":"A\u00a0new human prostate carcinoma cell line, 22Rv1","volume":"35","author":"Sramkoski","year":"1999","journal-title":"In\u00a0Vitro Cell. Dev. Biol. Anim."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16307501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16307501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T03:00:13Z","timestamp":1536721213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16307501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0006291X16307501"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.05.058","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoration of the cellular secretory milieu overrides androgen dependence of in\u00a0vivo generated castration resistant prostate cancer cells overexpressing the androgen receptor","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.05.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}